Comparing Perceptual Visual Quality of Hybrid Neural and Ray Tracing in Foveated Rendering
Journal on Interactive Systems · 15.05.2025 · 16 (1) · 328-342
DOI: 10.5753/jis.2025.5593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal on Interactive Systems, online erschienen am 15.05.2025. Verfasst von Horácio Henriques und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enabling Foveated Rendering for VR devices displays is fundamental when dealing with real-time ray tracing. Combining traditional methods with Neural based strategies, such as NeRFs and 3D Gaussian Splatting, may impact on leveraging performance even more. In this work we enhance and validate how well our traditional Instant-NeRF reconstructs common ray-traced effects through user metrics and quality metrics. We also show that 3D Gaussian Splatting used in the periphery vision area presents better results than the perceptual quality achieved through NeRFs. We present a deep human perception experiment through different global illumination light effects.
Zitieren
APA
Henriques, H., Oliveira, A. D., Oliveira, E., Clua, E., & Trevisan, D. (2025). Comparing Perceptual Visual Quality of Hybrid Neural and Ray Tracing in Foveated Rendering. Journal on Interactive Systems, 16(1), 328-342. https://doi.org/10.5753/jis.2025.5593
Vancouver
Henriques H, Oliveira AD, Oliveira E, Clua E, Trevisan D. Comparing Perceptual Visual Quality of Hybrid Neural and Ray Tracing in Foveated Rendering. Journal on Interactive Systems. 2025;16(1):328-342. doi:10.5753/jis.2025.5593
BibTeX
@article{Henriques2025,
author = {Henriques, Horácio and Oliveira, Alan de and Oliveira, Eder and Clua, Esteban and Trevisan, Daniela},
title = {Comparing Perceptual Visual Quality of Hybrid Neural and Ray Tracing in Foveated Rendering},
journal = {Journal on Interactive Systems},
year = {2025},
volume = {16},
number = {1},
pages = {328--342},
doi = {10.5753/jis.2025.5593}
}
EUVIMED